Suppr超能文献

[两种含2%卡替洛尔和2%毛果芸香碱滴眼液制剂在原发性开角型青光眼和单纯性眼压升高中的疗效及耐受性]

[Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].

作者信息

Sirbat D, Charlin J F, Cohn H, Dascotte J C, George J L, Lesure P, Massin M, Massin G, Maurin J F, Renard J P

机构信息

CHU de Rouen.

出版信息

J Fr Ophtalmol. 1995;18(10):589-96.

PMID:8568162
Abstract

PURPOSE

The aim of the study was to compare 2 combinations of eye drops containing 2% carteolol and 2% pilocarpine: LCM 1010: ready to use eye drops CBS 341A: eye drops to be reconstituted (freeze-dried powder + solvent).

METHODS

Ninety-seven patients with primary open angle glaucoma or simple ocular hypertension were included in a randomized, double-blind multicentric study comparing 2 parallel groups of treatment. Intra-ocular pressure was greater than 21 mmHg with beta-blocker alone. One instillation of 2% carteolol-2% pilocarpine combination was given twice a day for one month. Before and after this treatment, intra-ocular pressure was measured at 9 am (12 hours after evening instillation) and at 11 am (2 hours after morning instillation).

RESULTS

Both treatments reduced intra-ocular pressure by a comparable amount and there was no significant difference between groups at either measure: at 9 am: 2.11 +/- 2.39 mmHg (mean +/- SD) for LCM 1010 1.79 +/- 1.73 mmHg for CBS 341 A p = 0.25 at 11 am: 3.75 +/- 3.83 mmHg for LCM 1010 3.40 +/- 1.69 mmHg for CBS 341 A p = 0.42. Both eye drops were generally well tolerated.

CONCLUSION

Efficacy and safety of ready to use eye drops 2% carteolol-2% pilocarpine combination proved to be comparable to that of eye drops to be reconstituted in the treatment of ocular hypertension poorly controlled by beta-blocker eye drops alone.

摘要

目的

本研究旨在比较两种含2%卡替洛尔和2%毛果芸香碱的滴眼液组合:LCM 1010(即用型滴眼液)和CBS 341A(需重构的滴眼液,冻干粉末+溶剂)。

方法

97例原发性开角型青光眼或单纯性眼压升高患者纳入一项随机、双盲多中心研究,比较两个平行治疗组。仅使用β受体阻滞剂时眼压大于21 mmHg。每天两次滴注2%卡替洛尔-2%毛果芸香碱组合,持续1个月。在该治疗前后,于上午9点(晚上滴注后12小时)和上午11点(早晨滴注后2小时)测量眼压。

结果

两种治疗降低眼压的幅度相当,两组在任何一项测量中均无显著差异:上午9点:LCM 1010为2.11±2.39 mmHg(均值±标准差),CBS 341A为1.79±1.73 mmHg,p = 0.25;上午11点:LCM 1010为3.75±3.83 mmHg,CBS 341A为3.40±1.69 mmHg,p = 0.42。两种滴眼液总体耐受性良好。

结论

在治疗仅用β受体阻滞剂滴眼液控制不佳的眼压升高方面,即用型2%卡替洛尔-2%毛果芸香碱组合滴眼液的疗效和安全性被证明与需重构的滴眼液相当。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验